entertainment -WSS

entertainment

author：hotspot 2025-10-01 18:24:01 - browse：7

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Google and Epic fight stronger regulation of AI in health care

WSS

Google and Epic fight stronger regulation of AI in health care

Driven by the pandemic, applicants flood public health schools

Group opposing PBM reform sets lobbying record

At Orexo, a ‘turning point’ for everything but digital health

AI can’t replace a physician’s gut feeling

Google and Epic fight stronger regulation of AI in health care

knowledge

entertainment

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Biden tests positive for Covid

Moonlake's readout produced a cash windfall. Risks remain

I learned firsthand about improving diversity in clinical trials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves RSV monoclonal antibody for infants, toddlers

Jerome Adams on the need for new antivirals for Covid

Stanford president faces new allegations over 1999 paper

United colonoscopy coverage change 'may cost lives,' doctors say

Listen: Wegovy in the brain & pivotal Alzheimer's data

hotspot

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Vir antibody drug aimed at influenza A fails in clinical trial

How dance can help nurses traumatized by Covid

Tesla recalling nearly 16,000 of its 2021

Biden tests positive for Covid

Wikipedia

focus

explore

entertainment